AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
AcelRx Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
AcelRx Pharmaceuticals reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, three executives at AcelRx Pharmaceuticals received on average a compensation package of $923K, a 4% decrease compared to previous year.
Average pay of disclosed executives at AcelRx Pharmaceuticals
Vincent J. Angotti, Chief Executive Officer, received $1.2M in total, which decreased by 7% compared to 2022. 54% of Angotti's compensation, or $656K, was in salary. Angotti also received $346K in non-equity incentive plan, $163K in option awards, $34K in stock awards, as well as $13K in other compensation.
Pamela P. Palmer, Chief Medical Officer, received a compensation package of $814K, which decreased by 1% compared to previous year. 67% of the compensation package, or $542K, was in salary.
Raffi Asadorian, Chief Financial Officer, earned $743K in 2023, a 2% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2024.